March 15, 2024 07:00 AM EDTUpdated 03:10 PM

Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Biogen chief medical officer Maha Radhakrishnan is out after four years “as of March 1,” a spokesperson tells Peer Review. Biogen didn’t draw up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Jazz wins approval for bispecific in biliary tract cancer

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

At Jefferies, all that manufacturers want to talk about is GLP-1s

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

Are programs with compounded GLP-1s safe for your population?

Bio­gen los­es CMO, neu­ro­mus­cu­lar leader; John Hood adds pres­i­dent, CFO at En­deav­or Bio­Med­i­cines

Copy Chief

Editor

Sign up to read this article for free.

Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines